How does Bromocriptine affect the progression and management of pituitary adenomas, particularly in patients with elevated prolactin levels?
Gaurav ChauhanContributor
How does Bromocriptine affect the progression of pituitary adenomas?
Share
Bromocriptine, a dopamine agonist, inhibits prolactin secretion and can shrink pituitary adenomas, improving symptoms and reducing tumor size in patients with prolactinomas.
Bromocriptine, a dopamine agonist, effectively reduces prolactin secretion in patients with prolactinomas, leading to tumor shrinkage and symptom relief.